The increased expression of integrin α6 (itga6) enhances drug resistance in evi1 high leukemia

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Yamakawa, Norio ^a   Kaneda, Kazuko ^a   Saito, Yusuke ^a   Ichihara, Emi ^a   Morishita, Kazuhiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6 INTEGRIN; BETA4 INTEGRIN; LAMININ; SHORT HAIRPIN RNA; CELL ADHESION MOLECULE; COLLAGEN; DNA BINDING PROTEIN; ITGB4 PROTEIN, HUMAN; KALININ; MATRIGEL; MECOM PROTEIN, HUMAN; NEUTRALIZING ANTIBODY; PROTEOGLYCAN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL CULTURE; CANCER RELAPSE; CANCER RESISTANCE; CELL ADHESION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; LEUKEMIA; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL; CATTLE; CELL CYCLE; CELL STRAIN 3T3; CYTOLOGY; DRUG COMBINATION; DRUG RESISTANCE; GENE SILENCING; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; OSTEOBLAST; PATHOLOGY; PROTO ONCOGENE; RECURRENT DISEASE; TUMOR CELL LINE;

3T3 CELLS; ANIMALS; ANTIBODIES, NEUTRALIZING; CATTLE; CELL ADHESION; CELL ADHESION MOLECULES; CELL CYCLE; CELL LINE, TUMOR; COLLAGEN; DNA-BINDING PROTEINS; DOWN-REGULATION; DRUG COMBINATIONS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; INTEGRIN ALPHA6; INTEGRIN BETA4; LAMININ; LEUKEMIA, MYELOID, ACUTE; MICE; OSTEOBLASTS; PROTEOGLYCANS; PROTO-ONCOGENES; RECURRENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84856253727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030706     Document Type: Article

References (33)

1. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, et al. (1988) Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 54 (6): 831-840.
2. Mucenski L, Taylor BA, Ihle JN, Hartley JW, Morse HC 3rd, et al. (1988) Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol 8 (1): 301-308.
3. Morishita K, Parganas E, Bartholomew C, Sacchi N, Valentine MB, et al. (1990) The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5)(q25;q34) translocations. Oncogene Res 5 (3): 221-231.
4. Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, Valk PJ, van der Poel-van de Luytgaarde S, et al. (2001) High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 101 (3): 837-845.
5. Lugthart S, van Drunen E, van Norden Y, van Hoven A, Erpelinck CA, et al. (2008) High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 over-expression and chromosome 3q26 abnormalities underestimated. Blood 111 (8): 4329-4337.
6. Moroshita K, (2007) Leukemogenesis of the EVI1/MEL1 gene family. Int J Hematol 85 (4): 279-286.
7. Goyama S, Kurokawa M, (2010) Evi-1 as a critical regulator of leukemic cells. Int J Hematol 91 (5): 753-757.
8. Kurokawa M, Mitani K, Irie K, Matsuyama T, Takahashi T, et al. (1998) The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3. Nature 394 (6688): 92-96.
9. Nitta E, Izutsu K, Yamaguchi Y, Imai Y, Ogawa S, et al. (2005) Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP. Oncogene 24: 6165-6173.
10. Palmer S, Brouillet JP, Kilbey A, Fulton R, Walker M, et al. (2001) Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. J Biol Chem 276 (25): 834-840.
11. Yuasa H, Oike Y, Iwama A, Nishikata I, Sugiyama D, et al. (2005) Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. EMBO J 24 (11): 1976-1987.
12. Shimahara A, Yamakawa N, Nishikata I, Morishita K, (2010) Acetylation of lysine 564 adjacent to the C-terminal binding protein-binding motif in EVI1 is crucial for transcriptional activation of GATA2. J Biol Chem 285 (22): 16967-16977.
13. Lvesque JP, Helwani FM, Winkler IG, (2010) The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization. Leukemia 24 (12): 1979-1992.
14. Wu JY, Scadden DT, Kronenberg HM, (2009) Role of the osteoblast lineage in the bone marrow hematopoietic niches. J Bone Miner Res 24 (5): 759-764.
15. Chan JY, Watt SM, (2001) Adhesion receptors on heamatopoietic progenitor cells. Br J Haematol 112 (3): 541-557.
16. Zhang J, Niu C, Ye L, Huang H, He X, et al. (2003) Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425 (6960): 836-841.
17. Zaidel-Bar R, Geiger B, (2010) The switchable integrin adhesome. J Cell Sci 123 (9): 1385-1388.
18. Desgrosellier JS, Cheresh DA, (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10 (1): 9-22.
19. Papayannopoulou T, Craddock C, Nakamoto B, Priestley GV, Wolf NS, (1995) The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. PNAS 92 (21): 9647-9651.
20. Papayannopoulou T, Nakamoto B, (1993) Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. PNAS 90 (20): 9374-9378.
21. Matsunaga T, Takemoto N, Sato T, Takimoto R, Tanaka I, et al. (2003) Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 9 (9): 1158-1165.
22. Matsunaga T, Fukai F, Miura S, Nakane Y, Owaki T, et al. (2008) Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia. Leukemia 22 (2): 353-60.
23. Becker PS, Kopecky KJ, Wilks AN, Chien S, Harlan JM, et al. (2009) Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia. Blood 113 (4): 866-874.
24. Saito Y, Nakahata S, Yamakawa N, Kaneda K, Ichihara E, et al. (2011) CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression. Leukemia 25 (4): 921-31.
25. Bergamini C, Sgarra C, Trerotoli P, Lupo L, Azzariti A, et al. (2007) Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha6beta4 and alpha3beta1 integrins. Hepatology 46 (6): 1801-1809.
26. Fortunel NO, Otu HH, Ng HH, Chen J, Mu X, et al. (2003) Comment on "'Stemness': transcriptional profiling of embryonic and adult stem cells" and "a stem cell molecular signature". Science 302 (5644): 393.
27. Papayannopoulou T, Priestley GV, Nakamoto B, Zafiropoulos V, Scott LM, (2001) Molecular pathways in bone marrow homing: dominant role of α4β1 over β2-integrins and selectins. Blood 98 (8): 2403-2411.
28. Scott LM, Priestley GV, Papayannopoulou T, (2003) Deletion of α4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol 23 (24): 9349-9360.
29. Verhaak RG, Wouters BJ, Erpelinck CA, Abbas S, Beverloo HB, et al. (2009) Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica 94 (1): 131-134.
30. Yagi T, Morimoto A, Eguchi M, Hibi S, Sako M, et al. (2003) Identification of a gene expression signature associated with pediatric AML prognosis. Blood 102 (5): 1849-1856.
31. Lin KT, Yeh SH, Chen DS, Chen PJ, Jou YS, (2005) Epigenetic activation of a4, b2 and b6 integrins involved in cell migration in trichostatin A-treated Hep3B cells. J Biomed Sci 12 (5): 803-813.
32. Liu Y, Chen L, Ko TC, Fields AP, Thompson EA, (2006) Evi1 is a survival factor which conveys resistance to both TGF-beta and taxol-mediated cell death via PI3K/AKT. Oncogene 25 (25): 3565-3575.
33. Bei L, Lu Y, Bellis SL, Zhou W, Horvath E, et al. (2007) Identification of a HoxA10 Activation Domain Necessary for Transcription of the Gene Encoding beta 3 integrin during Myeloid Differentiation. J Biol Chem 282 (23): 16846-16859.